How much is FSD pharma stock worth?
One share of FSDDF stock can currently be purchased for approximately $0.84. How much money does FSD Pharma make? FSD Pharma has a market capitalization of $6.37 million and generates $70 thousand in revenue each year. How can I contact FSD Pharma? The company can be reached via phone at (416) 854-8884.
What does FSD Pharma Inc do?
Description. FSD Pharma Inc. operates as a cannabis company in Canada. It is involved in hydroponic indoor cannabis production and processing activities. The company, through its subsidiary, FV Pharma Inc., holds license to produce marijuana under the Access to Cannabis for Medical Purposes Regulations.
Is FSD Pharma (FSD) a good buy with a negative PE ratio?
Only 3.06% of the stock of FSD Pharma is held by institutions. The P/E ratio of FSD Pharma is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
What companies do other FSD Pharma investors own?
Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include JD.com (JD), Docebo (DCBO), salesforce.com (CRM), Canadian Natural Resources (CNQ), Chipotle Mexican Grill (CMG), Cloudera (CLDR), Caterpillar (CAT), Black Stone Minerals (BSM), Best Buy (BBY) and Alibaba Group (BABA).
Will FSD Pharma stock go up?
The Wall Street analyst predicted that FSD PHARMA's share price could reach $10.00 by Nov 13, 2021. The average FSD PHARMA stock price prediction forecasts a potential upside of 890.1% from the current HUGE share price of $1.01.
Is huge a good buy?
FSD Pharma Inc (NASDAQ:HUGE) The 1 analysts offering 12-month price forecasts for FSD Pharma Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 10.00. The median estimate represents a +952.63% increase from the last price of 0.95.
How many shares does FSD Pharma have?
38.49MFSD Pharma Inc.Volume143.13KShares Outstanding38.49MEPS (TTM)-$0.8341P/E Ratio (TTM)N/ADividend YieldN/A7 more rows
How do I buy a large stock?
Shares of HUGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are FSD Pharma's key executives?
FSD Pharma's management team includes the following people: Mr. Anthony John Durkacz , Founder & Co-Chairman (Age 43) Dr. Raza Bokhari M.B.A. ,...
Who are some of FSD Pharma's key competitors?
Some companies that are related to FSD Pharma include Acreage (ACRZF) , Core One Labs (CLABD) , Costa Group (CTTQF) , Feel Foods (FLLLF) , Fir...
What is FSD Pharma's stock symbol?
FSD Pharma trades on the OTCMKTS under the ticker symbol "FSDDF."
How do I buy shares of FSD Pharma?
Shares of FSDDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is FSD Pharma's stock price today?
One share of FSDDF stock can currently be purchased for approximately $1.01.
How much money does FSD Pharma make?
FSD Pharma has a market capitalization of $7.66 million and generates $70 thousand in revenue each year.
How can I contact FSD Pharma?
The company can be reached via phone at (416) 854-8884 .
Who are FSD Pharma's key executives?
FSD Pharma's management team includes the following people: Mr. Zeeshan Saeed , Founder, Pres & Exec. Co-Chairman (Age 52, Pay $225.27k) Mr. Ant...
Who are some of FSD Pharma's key competitors?
Some companies that are related to FSD Pharma include Valens (VLNS) , Auxly Cannabis Group (XLY) , Cardiol Therapeutics (CRDL) , Charlotte's We...
What other stocks do shareholders of FSD Pharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include JD.com (JD) , Docebo (DC...
What is FSD Pharma's stock symbol?
FSD Pharma trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUGE."
Who are FSD Pharma's major shareholders?
FSD Pharma's stock is owned by many different retail and institutional investors. Top institutional shareholders include AdvisorShares Investments...
Which major investors are selling FSD Pharma stock?
HUGE stock was sold by a variety of institutional investors in the last quarter, including Virtu Financial LLC, and Group One Trading L.P..
Which major investors are buying FSD Pharma stock?
HUGE stock was bought by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC, Renaissance Technologie...
How do I buy shares of FSD Pharma?
Shares of HUGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is FSD Pharma's stock price today?
One share of HUGE stock can currently be purchased for approximately $1.00.
What does a high stock score mean for FSD?
Stockchase rating for FSD Pharma Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
What is the symbol for FSD?
What is FSD Pharma Inc stock symbol? FSD Pharma Inc is a OTC stock, trading under the symbol HUGE-CN on the (). It is usually referred to as or HUGE-CN.
About FSD Pharma
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company.
FSD Pharma (NYSE:HUGE) Frequently Asked Questions
FSD Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022. View our earnings forecast for FSD Pharma.
Are investors shorting FSD Pharma?
FSD Pharma saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 411,900 shares, a decrease of 37.3% from the January 15th total of 656,700 shares. Based on an average daily trading volume, of 225,000 shares, the days-to-cover ratio is currently 1.8 days.
When is FSD Pharma's next earnings date?
FSD Pharma is scheduled to release its next quarterly earnings announcement on Tuesday, March 15th 2022. View our earnings forecast for FSD Pharma.
Who are some of FSD Pharma's key competitors?
Some companies that are related to FSD Pharma include Aeglea BioTherapeutics (AGLE), 9 Meters Biopharma (NMTR), Satsuma Pharmaceuticals (STSA), Molecular Templates (MTEM), NextCure (NXTC), Inozyme Pharma (INZY), InflaRx (IFRX), Matinas BioPharma (MTNB), Bolt Biotherapeutics (BOLT), Savara (SVRA), ContraFect (CFRX), Synlogic (SYBX), ProMetic Life Sciences (PFSCF), Sesen Bio (SESN) and Humanigen (HGEN). View all of HUGE's competitors..
What other stocks do shareholders of FSD Pharma own?
Based on aggregate information from My MarketBeat watchlists, some companies that other FSD Pharma investors own include Aurora Cannabis (ACB), Acasti Pharma (ACST), Allena Pharmaceuticals (ALNA), Assertio (ASRT), Bionano Genomics (BNGO), Ideanomics (IDEX), Stealth BioTherapeutics (MITO), Millendo Therapeutics (MLND), 9 Meters Biopharma (NMTR) and Selecta Biosciences (SELB)..
How do I buy shares of FSD Pharma?
Shares of HUGE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is FSD Pharma's stock price today?
One share of HUGE stock can currently be purchased for approximately $0.88.
How much money does FSD Pharma make?
FSD Pharma has a market capitalization of $35.57 million and generates $190 thousand in revenue each year. The company earns $-31.80 million in net income (profit) each year or ($1.12) on an earnings per share basis.
What is FSD 201?
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 diseas...
Does FSD Pharma have past data?
But as FSD Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions. This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data. Show section.
